Navigation Links
New Minimally Invasive Breast Reconstructive Procedure for Breast Cancer Patients - Actively Recruiting Participants for Clinical Study
Date:10/16/2007

MIAMI, Oct. 16 /PRNewswire/ -- Roger K. Khouri, M.D. a noted Plastic and Reconstructive Surgeon, is presently leading a team of surgeons in a clinical trial performing a minimally invasive breast reconstruction technique utilizing the Brava external expansion system and liposuctioned micro-fat grafts primarily on women who have had a mastectomy or lumpectomy, with or without radiation therapy.

Typically, breast reconstruction procedures involve major, "open" surgery that requires extensive recovery time. With this new minimally-invasive outpatient breast reconstruction technique, the chest wall is first expanded by using the Brava System and is followed by the re-injection of small micro- grafts that are harvested, through a liposuction procedure, from the patients own body (autologous grafts). These micro-fat grafts are most often harvested from the patient's thighs, buttocks and stomach. A key element to the success of this procedure, an average 90% graft survival rate, is the preparation of the recipient breast site with the expansion device (Brava) enabling greater volumes of fat to be transferred, and its post operative use to stabilize the graft ensuring its survival. Slowly, after undergoing a few procedures, the breasts are reconstructed. Following each treatment, patients are ambulatory and recovery time is minimal.

The study is actively recruiting the following types of participants: post lumpectomy patients, post mastectomy patients or those post breast biopsy, that were left with a filling defect, who do not have breast implants. Further information about the clinical trial and enrollment criteria may be found at http://www.clinicaltrials.gov/ct/show/NCT00466765?order=1

About Dr. Khouri

Roger K. Khouri, M.D., is a world renowned plastic and reconstructive surgeon practicing in Miami, FL and the inventor of the Brava System. Prior to co-founding Brava, LLC, Dr. Khouri held professional and fellowship positions at Brown, Harvard, New York and Washington Universities.

About Brava, LLC

Brava, LLC, founded in 1999, is a medical device manufacturer. Products include the Brava Breast Enhancement System. Brava, LLC headquarters are located at 14221 S.W. 142nd Street, Miami, FL 33186


'/>"/>
SOURCE Brava, LLC
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Non-Invasive Diagnostic Tests for Celiac Disease
2. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
3. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
4. Peer Reviewed Journal Article Indicates Repros Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer
5. Mayo Clinic News Release: Mayo Clinic-led Study Improves Breast Cancer Risk Prediction in Women with Atypia
6. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
7. First single breast cancer study to show significant survival benefit for women switching from tamoxifen to Arimidex
8. Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal Women with Early Breast Cancer Receiving Treatment with Tamoxifen
9. Women Well-Informed About Breast Cancer, Yet Lacking Knowledge About Current Treatments, New Survey Finds
10. Clinical Results From EntreMeds Panzem NCD and Taxol Breast Cancer Study Presented at ASCO
11. New Study Shows Doxorubicin Plus Paclitaxel Followed by Weekly Paclitaxel as Adjuvant Therapy for High Risk Breast Cancer Warranted in Place of Doxorubicin Plus Cyclophosphamide Followed by Paclitaxel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... , Feb 22, 2017 Research and ... Market Analysis & Trends - Industry Forecast to 2025" report to ... The Global ... around 5.2% over the next decade to reach approximately $2.1 billion by ... and forecasts for all the given segments on global as well as ...
(Date:2/22/2017)... Calif. , Feb. 22, 2017  Applied Silver, the ... Barnes to the company,s advisory board. Ms. Barnes is ... joining business, advertising, engineering, legal, and healthcare experts Scott ... John Goodrich , J. Tress Ritter , and ... BSN, CIC, FAPIC brings more than three decades of nationally ...
(Date:2/22/2017)... 2017 Oncternal Therapeutics, Inc., a clinical-stage ... and common malignancies, today announced the closing of ... intends to use the proceeds to further clinical ... advance preclinical development of a new ROR1-targeted antibody-drug ... first-in-class anti-ROR1 monoclonal antibody being developed to treat ...
Breaking Medicine Technology:
(Date:2/22/2017)... ... February 22, 2017 , ... The ... today, as organizations, advocates, and individuals join together to increase recognition about the ... ultimately save lives. , “Today we mark a nationwide movement to raise awareness ...
(Date:2/22/2017)... ... February 22, 2017 , ... A product of digesting a ... derive a heart-protective benefit from eating soy foods, while others do not, a University ... are able to produce equol—a substance made by some types of “good” gut bacteria ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... Pet obesity ... and 54% of dogs, according to the Association for Pet Obesity Prevention (APOP). During ... key pet food issues such as the benefits of corn and grains, value of ...
(Date:2/22/2017)... ... 22, 2017 , ... In a recent article ... context (age, illness and life choices) should be dissociated from medical errors and ... In addition, all too often, studies regarding health system performance in other countries, ...
(Date:2/21/2017)... , ... February 21, 2017 , ... ... Nation Regional Medical Clinic in Durant, Oklahoma, on Feb. 21. , The celebration ... tours for community members, clinic employees, the construction team and tribal leadership. ...
Breaking Medicine News(10 mins):